Like Pharma Executives Before Them, Pharmacy Benefit Managers Escape Largely Unscathed From High-Profile Hearing

This post was originally published on this site

Senate Finance Committee Chairman Chuck Grassley (R-Iowa) made it abundantly clear at Tuesday’s high-profile hearing that he is not intent on regulating PBMs out of business. Even though PBMs have weathered much of the blame lately for high drug prices, most of the pointed questions at the hearing fell flat.